Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

WSU neurodegenerative disease drug spinout Athira Pharma will put the proceeds towards phase 2/3 clinical testing of a treatment for Alzheimer's disease.

The classified listings group is putting up about $46m for Info Edge Venture Fund and expects to mobilise external backers to hit a $100m target.

Medical consultation platform developer Ubie has received $18.4m from medicine distributor Suzuken that will be used to enhance its apps, increase headcount and expand internationally.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Novartis bought $10m in shares as the fibrosis treatment developer floated at the top of its range in an expanded initial public offering.

Circulating tumour DNA blood test developer Base Genomics has raised $11m to progress research out of University of Oxford.

NodThera, a developer of treatments for conditions caused by chronic inflammation, has completed a Novo Ventures-led round that also featured Sanofi Ventures.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.